Published in J Cataract Refract Surg on February 01, 2013
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature (2009) 18.39
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature (2011) 13.30
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature (2011) 13.18
Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA (2009) 13.00
International study of the prevalence and outcomes of infection in intensive care units. JAMA (2009) 11.57
Mutational processes molding the genomes of 21 breast cancers. Cell (2012) 11.22
The life history of 21 breast cancers. Cell (2012) 10.59
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33
A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med (2008) 7.73
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study. J Clin Oncol (2007) 7.67
Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med (2003) 7.32
A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer. J Clin Oncol (2008) 5.56
C.A.U.S.E.: Cardiac arrest ultra-sound exam--a better approach to managing patients in primary non-arrhythmogenic cardiac arrest. Resuscitation (2007) 5.04
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol (2003) 3.31
Accelerated corneal crosslinking concurrent with laser in situ keratomileusis. J Cataract Refract Surg (2012) 2.72
Effect of complete epithelial debridement before riboflavin-ultraviolet-A corneal collagen crosslinking therapy. J Cataract Refract Surg (2008) 2.66
Clinician predictions of intensive care unit mortality. Crit Care Med (2004) 2.65
Optical coherence tomography may be used to predict visual acuity in patients with macular edema. Invest Ophthalmol Vis Sci (2011) 2.45
Activated protein C and septic shock: a propensity-matched cohort study*. Crit Care Med (2012) 2.39
Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer. Cell (2012) 2.37
Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron (2003) 2.19
Graded anterior transposition of the inferior oblique muscle for V-pattern strabismus. J AAPOS (2012) 2.08
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study. J Clin Oncol (2008) 2.02
CORRELATION OF CHOROIDAL THICKNESS AND BODY MASS INDEX. Retina (2015) 1.95
The importance of mosquito behavioural adaptations to malaria control in Africa. Evolution (2013) 1.93
Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med (2008) 1.93
A long-term study of photorefractive keratectomy; 12-year follow-up. Ophthalmology (2004) 1.92
Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue. J Clin Oncol (2011) 1.84
Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am J Respir Cell Mol Biol (2005) 1.83
Single-cell paired-end genome sequencing reveals structural variation per cell cycle. Nucleic Acids Res (2013) 1.77
Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study. Crit Care Med (2014) 1.72
Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis. Crit Care Med (2012) 1.71
5-year follow-up of LASIK for hyperopia. Ophthalmology (2005) 1.66
CaMKII-independent effects of KN93 and its inactive analog KN92: reversible inhibition of L-type calcium channels. Biochem Biophys Res Commun (2006) 1.63
Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy. Mol Ther (2010) 1.63
A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease. Mol Genet Metab (2007) 1.61
Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Am J Ophthalmol (2011) 1.56
The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models. Genome Biol (2013) 1.54
The current status and future direction of percutaneous coronary intervention without on-site surgical backup: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv (2007) 1.53
Targeting specific PDZ domains of PSD-95; structural basis for enhanced affinity and enzymatic stability of a cyclic peptide. Chem Biol (2004) 1.49
Fourier analysis of induced irregular astigmatism. Photorefractive keratectomy versus laser in situ keratomileusis in a bilateral cohort of hyperopic patients. J Cataract Refract Surg (2003) 1.49
Transconjunctival dacryocystorhinostomy: scarless surgery without endoscope and laser assistance. Ophthal Plast Reconstr Surg (2011) 1.48
Effects of ablation diameter on long-term refractive stability and corneal transparency after photorefractive keratectomy. Ophthalmology (2006) 1.47
Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand (2006) 1.47
Open source clinical science for emerging infections. Lancet Infect Dis (2014) 1.47
Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat Genet (2013) 1.45
Duration of Antimicrobial Treatment for Bacteremia in Canadian Critically Ill Patients. Crit Care Med (2016) 1.44
Important issues in the design and reporting of clinical trials in severe sepsis and acute lung injury. J Crit Care (2008) 1.43
Failure of a discontinuous bend to prevent lens epithelial cell migration in vitro. J Cataract Refract Surg (2002) 1.42
HPV types in Turkey: multicenter hospital based evaluation of 6388 patients in Turkish gynecologic oncology group centers. Turk Patoloji Derg (2013) 1.40
Effects of posterior capsular opacification on the evaluation of retinal nerve fiber layer as measured by Stratus optical coherence tomography. Can J Ophthalmol (2012) 1.40
SAP97 and CASK mediate sorting of NMDA receptors through a previously unknown secretory pathway. Nat Neurosci (2009) 1.40
Five-year clinical follow-up after implantation of the Endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human study. Catheter Cardiovasc Interv (2009) 1.39
Influence of perceived functional and employment status on cardiopulmonary resuscitation directives. J Crit Care (2003) 1.39
Life-threatening danger and suppression of attention bias to threat. Am J Psychiatry (2010) 1.39
Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. Cancer Cell (2003) 1.38
Actinfilin is a Cul3 substrate adaptor, linking GluR6 kainate receptor subunits to the ubiquitin-proteasome pathway. J Biol Chem (2006) 1.38
Photochemical kinetics of corneal cross-linking with riboflavin. Invest Ophthalmol Vis Sci (2012) 1.37
A randomized controlled trial of laparoscopic nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: One-year follow-up. Surg Innov (2006) 1.37
3D collagen orientation study of the human cornea using X-ray diffraction and femtosecond laser technology. Invest Ophthalmol Vis Sci (2009) 1.36
Mining biomarkers in human sera using proteomic tools. Proteomics (2004) 1.30
Multiple trafficking signals regulate kainate receptor KA2 subunit surface expression. J Neurosci (2003) 1.29
Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study. Arch Intern Med (2008) 1.28
A multidisciplinary program for delivering primary care to the underserved urban homebound: looking back, moving forward. J Am Geriatr Soc (2006) 1.28
Resilience in the third year of medical school: a prospective study of the associations between stressful events occurring during clinical rotations and student well-being. Acad Med (2009) 1.27
The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages. Endocrinology (2006) 1.26
Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma (2004) 1.25
Intracorneal inlay to correct presbyopia: Long-term results. J Cataract Refract Surg (2011) 1.23
Effect of epithelial retention and removal on riboflavin absorption in porcine corneas. J Refract Surg (2009) 1.21
Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth. Cancer Res (2004) 1.21
Assessment of delirium in the intensive care unit: nursing practices and perceptions. Am J Crit Care (2008) 1.21
A norovirus intervariant GII.4 recombinant in Victoria, Australia, June 2016: the next epidemic variant? Euro Surveill (2016) 1.20
Insulin-like growth factor-1 modulation of CaV1.3 calcium channels depends on Ca2+ release from IP3-sensitive stores and calcium/calmodulin kinase II phosphorylation of the alpha1 subunit EF hand. J Neurosci (2006) 1.18
AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease. J Gene Med (2006) 1.17
Inhibition of glycogen biosynthesis via mTORC1 suppression as an adjunct therapy for Pompe disease. Mol Genet Metab (2010) 1.17
Age-related differences in the elasticity of the human cornea. Invest Ophthalmol Vis Sci (2011) 1.15
A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes. Surg Endosc (2011) 1.15
Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway. Sci Signal (2009) 1.14
Intracorneal inlay for the surgical correction of presbyopia. J Cataract Refract Surg (2008) 1.13
Impairment of TrkB-PSD-95 signaling in Angelman syndrome. PLoS Biol (2013) 1.13
Growth factors in corneal wound healing following refractive surgery: A review. Acta Ophthalmol Scand (2002) 1.13
Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer. Clin Cancer Res (2008) 1.12
Age-related alterations in the diffusional transport of amino acids across the human Bruch's-choroid complex. J Opt Soc Am A Opt Image Sci Vis (2002) 1.10
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation (2004) 1.10
Reliability of the visual assessment of cervical and lumbar lordosis: how good are we? Spine (Phila Pa 1976) (2003) 1.09
The PDZ1 domain of SAP90. Characterization of structure and binding. J Biol Chem (2001) 1.09
Allosteric regulation and spatial distribution of kainate receptors bound to ancillary proteins. J Physiol (2003) 1.09
Cell surface expression of GluR5 kainate receptors is regulated by an endoplasmic reticulum retention signal. J Biol Chem (2003) 1.08
The design of randomized clinical trials in critically ill patients. Chest (2002) 1.07
Brucellosis and uveitis. Ann Ophthalmol (Skokie) (2008) 1.06
Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium. Clin Chem (2007) 1.06